Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8UD63

Entry ID Method Resolution Chain Position Source
AF-Q8UD63-F1 Predicted AlphaFoldDB

No variants for Q8UD63

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8UD63

No associated diseases with Q8UD63

5 regional properties for Q8UD63

Type Name Position InterPro Accession
domain Pyruvate carboxyltransferase 30 - 307 IPR000891
conserved_site Alpha-isopropylmalate/homocitrate synthase, conserved site 37 - 53 IPR002034-1
conserved_site Alpha-isopropylmalate/homocitrate synthase, conserved site 239 - 252 IPR002034-2
domain 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain 296 - 553 IPR013709
domain LeuA, N-terminal catalytic TIM barrel domain 29 - 311 IPR039371

Functions

Description
EC Number 2.3.3.13 Acyl groups converted into alkyl groups on transfer
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
2-isopropylmalate synthase activity Catalysis of the reaction: 3-methyl-2-oxobutanoate + acetyl-CoA + H(2)O = (2S)-2-isopropylmalate + CoA + H(+).

1 GO annotations of biological process

Name Definition
leucine biosynthetic process The chemical reactions and pathways resulting in the formation of leucine, 2-amino-4-methylpentanoic acid.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MTDASVKYRP YPTINIPDRT WPGKTIDKAP IWCSVDLRDG NQSLVNPMGH DRKARMFKLL
70 80 90 100 110 120
LEMGFKEIEI GFPSASQTDF DFARWCVEEG NVPDDVSLQV LVQCRPELIT RTFEALEGAN
130 140 150 160 170 180
KPIIHFYNST SELQRRVVFG KDVHGIKQIA VDAAKMITDM AAKAGGGFRF EYSPESFTGT
190 200 210 220 230 240
ELEVALEICN AVVEVVKPTA DNKLILNLPS TVEMATPNIY ADQIEWMCRN IDNRENVIIS
250 260 270 280 290 300
LHPHNDRGTG IAATELALMA GADRVEGTLF GNGERTGNVD VVTLALNMYT QGVDPELDCR
310 320 330 340 350 360
DIERIKAVYE YSNEMTIPER HPYVGELVYT AFSGSHQDAI NKGMKAIKVA NHPVWEVPYL
370 380 390 400 410 420
PIDPKDVGRS YEAIIRINSQ SGKGGIAYIL QQDYGINLPR NLQVEFREDI QRITDEEGVE
430 440 450 460 470 480
LPAKRIYERF IERYVTQPNA RIKFVDHHTY PAGDFKGVRI VAAEITDNGE VKRIEGKGTG
490 500 510 520 530 540
PIDGFINALS VYLGVDLSVN DYSEHSLQHG SNASAIAYVE MEHPGGKLFG AGVNTNIVAA
550
SLEAIVSAAN RVLEERAK